Self-assemblies with cascade effect to boost antitumor systemic immunotherapy.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Cancer Research

Background:

• Malignant tumors present a significant therapeutic challenge due to low cure rates.
• Developing effective strategies for targeted cancer treatment remains a critical need.
• Existing therapies often struggle with efficacy against both primary and distant tumor sites.

Purpose of the Study:

• To fabricate bio-organic hybrid self-assemblies with tumor-responsive and light-triggered nitric oxide (NO) release.
• To investigate the synergistic antitumor effects of a multi-level cascade strategy.
• To enhance the efficacy of cancer therapy against primary and distant tumors.

Main Methods:

• Fabrication of bio-organic hybrid self-assemblies using amino acids, conjugated polymers, Fe3+, and enzymes.
• Incorporation of tumor environment-responsive and light-triggered NO release capabilities.
• Evaluation of a three-level cascade strategy involving starvation, NO release, and immune activation (FFPG).

Main Results:

• The developed FFPG exhibited tumor environment-responsive and light-triggered NO release.
• Sequential energy consumption, NO attack, and immune activation led to boosted antitumor activity.
• Significant efficacy was observed against both primary and distant tumors.

Conclusions:

• The FFPG demonstrates a promising approach for enhanced antitumor activity through a multi-stage cascade.
• This strategy addresses the limitations of current cancer therapies, particularly for malignant tumors.
• The developed self-assembly offers a potential pathway to improve the cure rate of malignant tumors.